Invenomic Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Invenomic Capital Management's MDT Position: Q2 2026 in Review
Invenomic Capital Management opened a new position in Medtronic (MDT) in Q2 2026: 152,330 shares worth $11.9M. The stake represents 0.71% of the portfolio and ranks #50 among its holdings. This is a return to the name: Invenomic Capital Management previously reported a position in MDT as recently as Q1 2023.
Invenomic Capital Management first reported a position in MDT in Q4 2022 and has held it in 3 quarters since. The position peaked at $15.3M in Q1 2023. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Invenomic Capital Management held 152,330 shares of Medtronic worth $11.9M as of Q2 2026.
- Medtronic was a new Invenomic Capital Management position in Q2 2026.
- Medtronic made up 0.71% of Invenomic Capital Management's portfolio in Q2 2026, its #50 holding.
- Invenomic Capital Management first reported a position in Medtronic in Q4 2022 and has held it in 3 quarters since.
- Invenomic Capital Management's Medtronic position peaked at $15.3M in Q1 2023.
- 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.